PD-L1 blockade potentiates the antitumor effects of ALA-PDT and optimizes the tumor microenvironment in cutaneous squamous cell carcinoma

Immune checkpoint blockade (ICB) is a powerful oncologic treatment modality for a wide variety of human malignancies, but the patient response rate to this treatment remains low, especially in patients with cutaneous squamous cell carcinoma (cSCC). 5-Aminoleuvulinic acid-photodynamic therapy (ALA-PD...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeng, Qingyu, Yang, Jiayi, Ji, Jie, Wang, Peiru, Zhang, Linglin, Yan, Guorong, Wu, Yuhao, Chen, Qi, Liu, Jia, Zhang, Guolong, Wang, Xiuli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8986186/
https://www.ncbi.nlm.nih.gov/pubmed/35402079
http://dx.doi.org/10.1080/2162402X.2022.2061396

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8986186/
https://www.ncbi.nlm.nih.gov/pubmed/35402079
http://dx.doi.org/10.1080/2162402X.2022.2061396

Ejemplares similares